Injectable Drug Delivery Market Rising in United States | Emerging Technologies, Future Scope
The global injectable drug delivery market is anticipated to rise at a CAGR of 12.9% to reach USD 1,251.28 billion by the end of 2027 owing to the increasing prevalence of various diseases and the need for easy drug delivery to various target sites. Injectable drug delivery helps to provide effective drug delivery experience with speedy delivery. It is also considered as one of the most efficient routes of administration, thus ensuring improved patient experience. As per a report by Fortune Business Insights, titled, “Injectable Drug Delivery Market Size, Share & COVID-19 Impact Analysis, By Device Type (Conventional Injectable, Pre-filled syringes, Auto- injectors, Pen Injectors, and Wearable), By Product Type (Freeze-dried Products, Injectable Sterile Products), By End User (Hospitals, Homecare Settings, Clinics, and Others), and Regional Forecast, 2020-2027,” the value of this market was USD 483.45 billion in the year 2019 and the forecast period is set between 2020 and 2027.
Get Sample PDF Brochure:
https://www.fortunebusinessinsights.com/enquiry/sample/injectable-drug-delivery-market-101044
Increasing Popularity of Minimally Invasive Diagnostics to Bolster
Growth
The increasing prevalence of various diseases such as diabetes, cancer,
heart diseases, psoriasis, rheumatoid disease, and others stands as the key
factor boosting the global injectable drug delivery market growth. In addition
to this, the current COVID-19 pandemic and the increasing number of coronavirus
cases worldwide are also propelling the demand for injectable drugs in the
market. Moreover, the advent of technological advancement in healthcare and
medical technology and the increasing popularity of minimally invasive
therapeutic procedures will help the market to gain impetus in the forecast
duration.
However, the high cost of devices may pose a major challenge to the
market. Nevertheless, the advent of smart healthcare devices such as wearables
and the rising inclination towards self-injecting drugs are likely to create
lucrative growth opportunities for the market in the near future.
A New Auto-Injector called HUMIRA Pen launched by Eisai and AbbVie for
Patient’s Convenience
The new Humira Pen was launched successfully by Eisai Co. Ltd., AbbVie
GK, and EA Pharma Co. Ltd., a subsidiary of Eisai Co. Ltd. Humira is the first
monoclonal antibody with anti-TNF-alpha used for treating autoimmune
diseases such as multiple sclerosis, rheumatoid arthritis, psoriasis, and
others. This auto-injector is user-friendly, which means that the patient can
easily operate it without assistance. The joint venture between these three
companies also aims at offering detailed information on the correct utilization
of HUMIRA to improve the overall quality of life of various patients. Such
initiatives are likely to aid in the expansion of the market in the coming
years.
Related Topics :
Drivers & Restraints-
Rising Awareness about Minimal Invasive Treatment Mode to Add Impetus
The rising geriatric population and their vulnerability to various
diseases stand as key factors boosting the global injectable drug delivery
market growth. This, coupled with the rising prevalence of chronic diseases
such as cancer, diabetes, heart disorders, and others will also add impetus to
the market. Moreover, clinical studies and the adoption of innovative products
for drug delivery are expected to boost the market growth. The current COVID-19
pandemic that has propelled the intensity of casualty cases in medical centers
all over the world is also aiding in the expansion of the market.
On the contrary, factors such as high cost of the devices and the lack
of adequate reimbursement policies may hamper the market growth in the coming
years. Nevertheless, the increasing adoption of minimally invasive treatment
methods and their ascending success rate are expected to create lucrative
growth opportunities for the market in the coming years.
Speak To Our Analyst:
About Us:
Fortune Business Insights™ delivers accurate data and innovative
corporate analysis, helping organizations of all sizes make appropriate
decisions. We tailor novel solutions for our clients, assisting them to address
various challenges distinct to their businesses. Our aim is to empower them
with holistic market intelligence, providing a granular overview of the market
they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Comments
Post a Comment